Skip to content
Unrated Drug recall · FDA · Published June 2, 2026

ANI Pharmaceuticals recalls hydrOXYzine oral solution due to foreign substance

ANI Pharmaceuticals recalls 10 mg/5 mL hydrOXYzine Hydrochloride Oral Solution (1 pint) due to foreign substance presence. Rx only product distributed by ANI Pharmaceuticals, Inc. in Baudette, MN. NDC: 70954-912-10, Lot S25133A.

🇺🇸 FDA recall #D-0619-2026DrugANI Pharmaceuticals ›
Take action

Contact the company

Recalling firmANI Pharmaceuticals, Inc.210 W Main St · Baudette, MN 56623-2467
✎ GovInfoNow plain-language explainer

ANI Pharmaceuticals is recalling a specific hydrOXYzine oral solution product because it contains a foreign substance. This recall affects prescription-only medication distributed by ANI Pharmaceuticals, Inc. in Baudette, MN. Read more at govinfonow.com/recall/31241-ani-pharmaceuticals-recalls-hydroxyzine-oral-solution-due-to-foreign-substance.

Source Summary by GovInfoNow · govinfonow.com/recall/31241-ani-pharmaceuticals-recalls-hydroxyzine-oral-solution-due-to-foreign-substance · Updated August 10, 2026 · FDA enforcement record: FDA #D-0619-2026

Cite this page

“ANI Pharmaceuticals recalls hydrOXYzine oral solution due to foreign substance.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/31241-ani-pharmaceuticals-recalls-hydroxyzine-oral-solution-due-to-foreign-substance. Based on FDA recall #D-0619-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0619-2026%22&limit=1).

The FDA announced on June 2, 2026, that ANI Pharmaceuticals is recalling hydrOXYzine Hydrochloride Oral Solution due to the presence of a foreign substance. The agency issued recall number D-0619-2026 for the nationwide distribution of the drug.

How to tell if you have it

  • Brand: ANI Pharmaceuticals
  • Product: hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint)
  • NDC: 70954-912-10
  • Lot code: S25133A
  • Quantity: 6564 bottles

The hazard

The recall is due to the presence of a foreign substance in the hydrOXYzine Hydrochloride Oral Solution. The FDA classified this as a Class III recall.

Context

ANI Pharmaceuticals has three other recalls on record since October 9, 2020, including a May 12, 2026, recall of Estradiol Gel due to defective containers and a February 15, 2022, recall of Alprazolam Tablets for manufacturing deviations. Other recent recalls of similar products include Graviti Furosemide Tablets Recall (January 10, 2026), Taro Recalls Children's Ibuprofen (March 2, 2026), and Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026).

How to tell if you have this one

Check for the product name 'hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint)' with NDC 70954-912-10 and lot number S25133A. This prescription-only medication was distributed by ANI Pharmaceuticals, Inc. in Baudette, MN.

  • Brand
    ANI Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC code 70954-912-10 and lot number S25133A on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 29 days after the firm started it.

1. Firm started the recall: Jun 2, 202612. FDA classified it Class III: Jun 24, 202623. Published in FDA’s Enforcement Report: Jul 1, 202632026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0619-2026 (June 2, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0619-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA